Yi Jiang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Retinal Development and Disorders 8
-
- Lung Cancer Treatments and Mutations 10
- Sarcoma Diagnosis and Treatment 7
- Co-authors
- Ling‐Qing Yuan (8 shared papers)Guohua Lv (7 shared papers)Xiaoling She (7 shared papers)Ming‐Xiang Zou (7 shared papers)Hongchen Liu (5 shared papers)Rongrong Cui (4 shared papers)Jing Li (5 shared papers)Xiaobin Wang (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Investigative Ophthalmology & Visual Science (8 papers)Annals of Oncology (4 papers)Frontiers in Oncology (4 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yi Jiang
146 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 135
- Cancer Research 393
- Hepatology 197
- Nephrology 118
- Oncology 450
- Rheumatology 230
Countries citing papers authored by Yi Jiang
This map shows the geographic impact of Yi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Jiang more than expected).
Fields of papers citing papers by Yi Jiang
This network shows the impact of papers produced by Yi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Jiang. The network helps show where Yi Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 188 | |
| 2 | 2015 | 94 | |
| 3 | 2021 | 90 | |
| 4 | 2014 | 82 | |
| 5 | 2005 | 78 | |
| 6 | 2012 | 72 | |
| 7 | 2014 | 58 | |
| 8 | 2011 | 56 | |
| 9 | 2012 | 51 | |
| 10 | 2016 | 51 | |
| 11 | 2012 | 50 | |
| 12 | 2020 | 50 | |
| 13 | 2013 | 48 | |
| 14 | 2017 | 42 | |
| 15 | 2014 | 41 | |
| 16 | 2013 | 41 | |
| 17 | 2018 | 38 | |
| 18 | 2010 | 37 | |
| 19 | 2018 | 37 | |
| 20 | 2019 | 36 |
About Yi Jiang
Yi Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 151 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Retinal Diseases and Treatments (8 papers), Retinal Development and Disorders (8 papers), Sarcoma Diagnosis and Treatment (7 papers), Amoebic Infections and Treatments (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). The work is most often cited by research in Cancer Research (393 citations), Hepatology (197 citations), Nephrology (118 citations), Oncology (450 citations) and Rheumatology (230 citations). Yi Jiang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ling‐Qing Yuan, Guohua Lv, Xiaoling She, Ming‐Xiang Zou, Hongchen Liu, Rongrong Cui, Jing Li, Xiaobin Wang, Qing Miao and Nan Hu. Their work appears in journals such as Journal of Clinical Oncology, Investigative Ophthalmology & Visual Science, Annals of Oncology, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.